Allspring Global Investments Holdings LLC Boosts Stock Holdings in Haleon plc (NYSE:HLN)

Allspring Global Investments Holdings LLC lifted its holdings in shares of Haleon plc (NYSE:HLN) by 11.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 28,474 shares of the company’s stock after purchasing an additional 2,914 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Haleon were worth $269,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Procyon Advisors LLC lifted its holdings in shares of Haleon by 41.3% in the fourth quarter. Procyon Advisors LLC now owns 230,240 shares of the company’s stock worth $2,196,000 after buying an additional 67,329 shares in the last quarter. HighTower Advisors LLC grew its stake in Haleon by 27.2% in the 3rd quarter. HighTower Advisors LLC now owns 350,795 shares of the company’s stock worth $3,701,000 after buying an additional 74,970 shares in the last quarter. Jane Street Group LLC increased its stake in Haleon by 1,689.4% in the third quarter. Jane Street Group LLC now owns 264,977 shares of the company’s stock valued at $2,803,000 after acquiring an additional 250,169 shares during the last quarter. Chartwell Investment Partners LLC lifted its position in Haleon by 107.8% in the 3rd quarter. Chartwell Investment Partners LLC now owns 475,415 shares of the company’s stock worth $5,030,000 after buying an additional 246,594 shares during the last quarter. Finally, Townsquare Capital LLC boosted its stake in Haleon by 29.8% in the third quarter. Townsquare Capital LLC now owns 475,618 shares of the company’s stock worth $5,032,000 after buying an additional 109,217 shares in the last quarter. 6.67% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several equities research analysts have weighed in on HLN shares. Sanford C. Bernstein cut shares of Haleon from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 8th. Morgan Stanley downgraded Haleon from an “overweight” rating to an “equal weight” rating in a report on Friday, January 10th. Three analysts have rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $10.95.

Haleon Stock Performance

Shares of NYSE:HLN opened at $10.16 on Wednesday. The stock has a market capitalization of $45.97 billion, a P/E ratio of 29.87, a PEG ratio of 2.82 and a beta of 0.28. Haleon plc has a 52 week low of $7.89 and a 52 week high of $10.80. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.44. The firm has a fifty day simple moving average of $9.57 and a two-hundred day simple moving average of $9.83.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.